Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report
Frontiers in Cardiovascular Medicine · 03.06.2026 · 13
DOI: 10.3389/fcvm.2026.1749534 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 03.06.2026. Verfasst von Yuqiang Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Lanzhou University, Lanzhou, China. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICIs) are pivotal in treating advanced malignancies, including hepatocellular carcinoma (HCC). However, they can trigger immune-related adverse events (irAEs), among which myocarditis is one of the most life-threatening. Herein, we report the case of a 56-year-old man with HCC who developed myocarditis after receiving two cycles of the PD-1 inhibitor sintilimab. The diagnosis was established via cardiac magnetic resonance (CMR) and confirmed by endomyocardial biopsy (EMB). Following treatment with high-dose corticosteroids and supportive therapy, the patient's condition exhibited significant improvement.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
- Department of Pathology, The First Hospital of Lanzhou University, Lanzhou, China.
- Department of Radiology, The First Hospital of Lanzhou University, Lanzhou, China.
- Departments of Radiological Sciences, University of California, Irvine, CA, United States.
Zitieren
APA
Zhou, Y., Zhang, Z., Liu, S., Nan, J., Zhang, Z., & Chen, Z. (2026). Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1749534
Vancouver
Zhou Y, Zhang Z, Liu S, Nan J, Zhang Z, Chen Z. Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1749534
BibTeX
@article{Zhou2026,
author = {Zhou, Yuqiang and Zhang, Zhiliang and Liu, Shasha and Nan, Jiang and Zhang, Zhuoli and Chen, Zixian},
title = {Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1749534}
}
EUVIMED